Related Experiment Videos
Mastocytosis in children: a protocol for management
Rogier Heide1, Auke Beishuizen, Hans De Groot
1Department of Dermatology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands.
Pediatric Dermatology
|September 16, 2008
Summary
Mastocytosis involves abnormal mast cell growth. In children, it typically affects the skin (cutaneous mastocytosis) and is often temporary, unlike the more severe adult form.
Area of Science:
- Pediatric Hematology
- Dermatology
- Oncology
Background:
- Mastocytosis is a rare disorder characterized by mast cell accumulation.
- Pediatric mastocytosis commonly presents as cutaneous mastocytosis, often transient.
- Adult mastocytosis is typically progressive and systemic.
Purpose of the Study:
- To provide a guideline for managing pediatric mastocytosis.
- To differentiate between childhood and adult mastocytosis.
- To outline diagnostic and management approaches for healthcare providers and parents.
Main Methods:
- Review of existing literature and clinical guidelines.
- Classification of mastocytosis subtypes in children.
- Development of a management protocol.
Main Results:
- Identified three common forms of cutaneous mastocytosis: maculopapulous, mastocytoma, and diffuse cutaneous.
- Distinguished between non-persisting and persisting cutaneous mastocytosis, and rare systemic mastocytosis in children.
- Recommended yearly checkups for most cases, with preventive measures for systemic disease and symptomatic therapy only when necessary.
Conclusions:
- Most childhood mastocytosis cases are cutaneous and resolve spontaneously.
- Systemic mastocytosis in children requires preventive strategies.
- A standardized management approach ensures appropriate care for pediatric mastocytosis patients.
Related Concept Videos
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...